Activating EGFR Mutation
2 clinical trials · Condition
◉ Watch Activating EGFR Mutation
| Record | Firm | Date |
|---|---|---|
| Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB (NCT02326285) | AIO-Studien-gGmbH | 2015-11-01 |
| ATOM_local Ablative Therapy (NCT01941654) | Chinese University of Hong Kong | 2013-09-18 |
Track Activating EGFR Mutation automatically
Every clearance here is in the API, with alerts when new ones post.